Congress intelligence for the life sciences industry · London Have an access code? Open your briefing →  ·  briefings@conferenceiq.co.uk
Congress intelligence consultancy

The congress is where competitors show their hand. We read every card.

ConferenceIQ gives pharma and biotech competitive intelligence teams first-hand intelligence from international medical congresses: KOL reaction, session readouts and competitor booth strategy, gathered on site against your key intelligence questions.

14–16International congresses covered each year
14Therapeutic and functional areas covered since 2024
~20Years of face-to-face KOL research at congresses
PhDLed by a Cambridge doctorate in pharmacology and neurology
US · EUOn site at North American and European meetings
Our focus
Most consultancies treat the congress as one source among many. For us it is the whole job. We do no desk research; every finding we deliver was gathered in person, at the meeting, by people who know the data, the investigators and the competitive landscape.
Flagship product · ConferenceIQ Booth Analyser

Every competitor stand, read like a strategy document.

Booth photographs and on-site observations, turned into a structured briefing on each competitor's messaging, investment and positioning shifts, tracked from congress to congress.

Page 1 of a real ConferenceIQ booth intelligence briefing, CHEST 2026, with company and product names blurredReal briefing · CHEST 2026 · 10 pages · names blurred
Congress calendar

Taking briefs for the 2027 season

From ASH in December to AHA in November, we cover the meetings that move your therapy area. See the full calendar and coverage

ASHWORLDSymposiumEAUACCAANAACRATSASCOEHAEULARSNMMIERSECTRIMSESMOAAOEANMAHASITC
The READ method

We READ the congress.

Every session, every stand, every signal.

  • RReadinessPlan, report daily, debrief
  • EExpert voicesKOL and investigator interviews
  • AAgenda intelligenceSessions, symposia, late-breakers
  • DDisplay intelligenceBooths, booth teams and MSLs
R

ReadinessCongress Readiness and Debrief

From KIQs to a decision your brand team can act on.

Pre-congress planning built around your priorities, daily flash reports while the meeting runs, and a full report and debrief once it closes.

  • KIQ development and session planning
  • Daily flash reporting during the congress
  • Full report structured by KIQ
  • Debrief with CI, brand and medical teams
E

Expert voicesKOL and Delegate Research

What the people who shape treatment think, in their own words.

Structured face-to-face interviews with investigators, KOLs and treating physicians at the congress, conducted against your KIQs and reported with verbatim evidence.

  • Reaction to new data as it is presented
  • Perceived positioning of your brand and competitors
  • Unmet need and likely prescribing impact
  • Verbatim quotes coded by KIQ
A

Agenda intelligenceSession and Symposium Intelligence

What was presented, how it landed, and what it means.

Coverage of the oral, poster and late-breaking sessions that matter to your portfolio, together with industry-sponsored satellite symposia, discussant commentary and audience questions.

  • Late-breaking abstracts and plenaries
  • Competitor satellite symposia and messaging
  • Discussant and room reaction
  • Implications for your brand and pipeline
D

Display intelligenceBooth and Exhibit-Hall Intelligence

A competitor's stand is its most expensive message. We read it, and talk to the people staffing it.

A structured assessment of each competitor stand using the ConferenceIQ Booth Analyser: messaging, claims, investment, staffing and how each has changed since the previous congress. Our analysts also talk openly with booth teams and medical science liaisons, capturing what each company chooses to say in person about its data, launch plans and positioning.

  • Key messages and claims on every panel
  • Conversations with booth staff and MSLs
  • Footprint, layout and headcount
  • Medical versus commercial presence
  • Tracked from congress to congress
Delegates moving between exhibition stands in a large congress hall
Display Every stand on the floor is a statement of strategy.
Approach

How a congress engagement runs

A disciplined process, refined over 20+ years of congress coverage, so your team gets intelligence it can act on while the meeting is still under way.

Weeks before

Define the questions

We agree KIQs, priority competitors and target sessions with your team, and identify the KOLs and investigators to approach.

Days before

Plan the coverage

A day-by-day plan maps every session, interview slot and exhibit-hall visit to a KIQ, with an interview guide signed off by you.

During

Gather and flash

Sessions, interviews and booth work run in parallel. Each evening you receive a flash report on what moved that day.

After

Report and debrief

A full report organised by KIQ, with verbatim evidence and booth analysis, followed by a debrief with your stakeholders.

Ways to engage

One congress, a full season, or a standing partnership

Choose the model that matches how your team plans its congress year. Each one comes with the same senior lead and the same KIQ-led reporting.

Single congress

A focused brief for one meeting

Coverage scoped to one congress and a defined set of KIQs, from a single day of KOL interviews to full five-day coverage. Ideal for a pivotal data readout or competitor launch.

Congress season programme

A planned year of priority meetings

An agreed calendar of congresses for one brand or franchise, with consistent KIQs, booth tracking from meeting to meeting and a season-end synthesis of how the landscape has moved.

Agency partnership

Specialist congress capacity for CI agencies

Senior, congress-experienced consultants who slot into your client programmes under your brand, from KIQ planning through on-site research to the final report.

Flagship product · ConferenceIQ Booth Analyser

Every competitor stand, read like a strategy document.

The Booth Analyser turns exhibit-hall photographs and on-site observations into a structured briefing on what each competitor is saying, who it is saying it to, and how its positioning has shifted since the last congress.

  • 01
    Messaging and claimsHeadline messages, claims and data highlighted on every panel and screen.
  • 02
    Investment and staffingStand size, layout and headcount, and the balance of medical and commercial staff.
  • 03
    Literature on standEvery brochure, leave piece and guide collected and scanned, with its key claims, data cited and approval codes.
  • 04
    Tracked across congressesEach stand is compared with the company's earlier booths, so positioning shifts stand out.
  • 05
    Read for your brandEvery briefing is written from your company's point of view, with a threat rating and implications.
Inside a real briefing

Fourteen sections, every claim traced to a photograph

This is a real ConferenceIQ briefing on one competitor's stand at CHEST 2026, written for a rival's brand team. Company names, product names and other identifying details are blurred. Choose a section to turn to its page.

    Sample briefing page 1
    Page 1 of 10
    01Your archiveSend booth photographs from past congresses for legacy briefings and an instant track record.
    02Live, via your agencyWe work alongside your congress agency to deliver briefings while the meeting runs.
    03Full coverageWe photograph and analyse the exhibit hall ourselves, timed to your schedule.
    04Self-serveYour team uploads its own photographs and generates briefings directly.

    See a briefing on your own competitors.Request an access code and we will prepare a complimentary briefing on one competitor stand from a recent congress, written from your company's point of view.

    Request an access code
    Case studies

    Three engagements, three ways of working

    From a single congress to a year-long monitoring programme, with or without the Booth Analyser. Every engagement starts from the client's key intelligence questions.

    01
    CardiometabolicLong-term monitoring

    Defending a market leader through a wave of once-weekly entrants

    The challenge

    The client's once-daily brand led its class, but four competitors were preparing once-weekly formulations and fixed-dose combinations. Press releases and secondary sources told the CI team what was coming. They could not tell it how each competitor would position, support and defend its launch, or how physicians were really responding.

    Key intelligence questions

    1. How is each competitor positioning its once-weekly option against the once-daily standard, and which patients will it target first?
    2. What switching messages and patient support programmes are reps and medical teams using?
    3. How are fixed-dose combinations being positioned against their individual components, and how are payer concerns being handled?
    4. Which device and formulation changes are coming, and on what timelines?
    5. How is the treatment pathway changing as physicians gain experience with the new entrants?

    Our solution

    Before each congress

    A KIQ workshop with CI, brand and medical teams set the year's priorities. Each congress then had its own planner, mapping every KIQ to sessions, industry symposia, posters and named targets, including poster presenters affiliated with competitor programmes.

    At the congress

    A two-person team engaged reps, MSLs and product managers on all four competitor stands. It covered every competitor symposium, capturing KOL and physician reactions as delegates left the room, and interviewed investigators in the poster hall. The team photographed the whole exhibit hall for the Booth Analyser.

    Between congresses

    Monthly telephone research with KOLs, investigators, payers and treating physicians kept the KIQs current, with email alerts whenever a high-impact finding emerged.

    What the client received

    • Daily flash reports during each congress
    • Booth Analyser briefings on all four competitor stands at every meeting, compared meeting to meeting
    • A full report organised by KIQ, with a debrief after each congress
    • A quarterly synthesis with a treatment pathway map updated through the year

    Impact

    Comparing the stands across three congresses showed one competitor moving from a medical-led presence to a full commercial stand ahead of launch. The brand team brought its switch-defence messaging and patient support plans forward by a full congress cycle.

    02
    PsychiatryAd hoc · single congress

    Five competitors and a treatment pathway, mapped in four days

    The challenge

    The client was preparing to launch into major depressive disorder, a market dominated by low-cost generics. Before finalising its positioning, the brand team needed to know where branded competitors were really placing themselves in the treatment pathway, how reps handled insurers' generic-first requirements, and whether pharmacogenomic testing was starting to shape prescribing.

    Key intelligence questions

    1. How are branded competitors positioning against generic first-line options, and at which line of therapy?
    2. What do reps and medical staff say about dosing, tolerability and sampling programmes?
    3. How do product theatre speakers discuss competitor data once they are off-script?
    4. How are pharmacogenomic tests promoted and reimbursed, and are they changing prescribing?
    5. Which pipeline programmes could enter as adjunctive therapy?

    Our solution

    Before the congress

    An agenda review flagged high-priority sessions and abstracts and set a schedule for booths and product theatres. A target list covered presenting KOLs and investigators.

    At the congress

    Our consultants spoke with reps and medical staff on all five stands. They covered every competitor product theatre and captured speaker and audience reactions immediately afterwards. They also engaged a pipeline company's medical leadership on its development plans, and photographed the exhibit hall for the Booth Analyser.

    After the congress

    The full report was delivered within two weeks, followed by a debrief with the brand and medical teams.

    What the client received

    • Daily email debriefs while the meeting ran
    • An exhibit-hall floor plan and Booth Analyser briefings on all five stands
    • Messaging and positioning for each brand, with verbatim quotes
    • A treatment pathway map showing where each competitor wants to sit against where physicians actually use it
    • A digest of priority sessions and abstracts

    Impact

    The pathway map exposed a gap between where competitors pitched their brands and where prescribers actually used them. It became the starting point for the client's positioning workshop, and the team commissioned coverage of the next meeting.

    03
    NeurodegenerationCongress season programme

    Booth intelligence from the client's own photographs, backed by investigator interviews

    The challenge

    Antibody therapies were now in clinical use, and the client needed to understand how the established players were shaping diagnosis, infusion logistics and patient identification. It also needed to know how competing trials were recruiting the same patients. Its medical team attended every congress but had no capacity to analyse competitor stands or run interviews.

    Key intelligence questions

    1. How are the market leaders messaging on safety monitoring, infusion capacity and patient eligibility?
    2. Which competitor trials are recruiting the same patient population, and how quickly?
    3. How are investigators reacting to new biomarker and blood-test data, and how will it change the diagnostic pathway?
    4. What are competitors' medical teams saying about upcoming readouts and next indications?

    Our solution

    Booth Analyser on the client's photographs

    The client's medical team photographed six competitor stands at each congress. We returned Booth Analyser briefings within 48 hours, and their photographs from earlier meetings gave every competitor an immediate track record.

    Targeted primary research on site

    One ConferenceIQ consultant spent two days at each meeting interviewing trial investigators and poster presenters, including those affiliated with competitor programmes, and engaging competitor MSLs on their stands.

    Tracking the pathway

    The same core questions were asked at all three meetings, so the client could see how the route from diagnosis to infusion was changing.

    What the client received

    • Six Booth Analyser briefings per congress, delivered within 48 hours
    • An investigator interview summary organised by KIQ, with verbatim quotes
    • A season-end synthesis on pathway evolution and competitor recruitment

    Impact

    A small team gained a full view of the exhibit hall without paying for full congress coverage. Investigator feedback on competing recruitment fed directly into the client's site-selection planning for its next study.

    These case studies represent the engagements we deliver. Client, product and competitor details are withheld for confidentiality.

    Have a congress coming up?

    Tell us your key intelligence questions and we will propose the right mix of coverage.

    Brief us
    Congresses

    Where we work

    The meetings we cover, the 2027 calendar and our therapeutic coverage since 2024.

    Congress calendar

    Planning for the 2027 congress season

    We are now taking briefs for the 2027 season. These are the meetings we cover most often; ask us about any congress not listed.

    Dec 2026ASHAmerican Society of Hematology Annual MeetingHaematology
    Feb 2027WORLDSymposiumLysosomal diseases research meetingRare disease
    Mar 2027EAU · ACCEuropean Association of Urology · American College of CardiologyUrology · Cardiology
    Apr 2027AAN · AACRAmerican Academy of Neurology · American Association for Cancer ResearchNeurology · Oncology
    May 2027ATS · ASCOAmerican Thoracic Society · American Society of Clinical OncologyRespiratory · Oncology
    Jun 2027EHA · EULAR · SNMMIEuropean Hematology Association · EULAR · Society of Nuclear Medicine and Molecular ImagingHaematology · Rheumatology · Imaging
    Sep 2027ERS · ECTRIMSEuropean Respiratory Society · European Committee for Treatment and Research in MSRespiratory · Neurology
    Oct 2027ESMO · AAO · EANMEuropean Society for Medical Oncology · American Academy of Ophthalmology · European Association of Nuclear MedicineOncology · Ophthalmology · Imaging
    Nov 2027AHA · SITCAmerican Heart Association · Society for Immunotherapy of CancerCardiology · Immuno-oncology

    Months show when each meeting usually takes place. Confirm exact dates with the congress organiser.

    Therapeutic coverage

    Fourteen therapy areas covered since 2024

    Recent coverage, combining hands-on KOL research with management of congress-based intelligence programmes. The bars show relative depth of coverage from 2024 to 2026.

    Therapy areaDepth, 2024–26Representative congresses
    About · Cambridge-founded · Pharma-built

    Scientific fluency. Commercial judgement. Congress-proven.

    Every ConferenceIQ engagement is staffed by a multidisciplinary team built for the brief: former pharmacists and medical information specialists, R&D scientists from industry and academia, and commercial strategists who have sat on the client side.

    ClinicalPharmacists and medical information

    Practitioners who read the data the way HCPs do, and speak to KOLs as peers.

    ScientificR&D, industry and academic

    PhD-qualified researchers who can separate a genuine signal from a well-staged poster.

    CommercialBrand, access and CI leadership

    Consultants who have built CI programmes for pharma and know what a brand team will do with the answer.

    AcademicCambridge-led rigour

    Founded and led by a University of Cambridge doctorate in pharmacology and neurology.

    Our people

    Senior-led. In the room.

    Every engagement is led by a senior consultant who attends the congress in person, so you speak directly to the person gathering your intelligence.

    Founder of ConferenceIQ
    Dr T. Lori Founder and Managing Director

    20+ years of congress intelligence, built from the ground up

    He began his career in academic research, completing a PhD in Pharmacology (Neurology) at the University of Cambridge. In 2006 he joined Deallus as an analyst, conducting face-to-face primary research at international medical congresses, and rose to Director of Research and Director of Training, where he designed the programme that taught new analysts conference attendance and elicitation techniques. He went on to lead CI accounts as an Account Director at CIS / Prescient Healthcare Group.

    Since 2011 he has run his own independent CI practice, acting as CI lead and senior advisor on global accounts for pharma companies and CI agencies. His recent coverage runs to 14–16 congresses a year, with particular depth in neurology, oncology, ophthalmology, cardiology and rare disease. ConferenceIQ brings that fieldwork to clients directly, as rapid booth intelligence briefings.

    • 2011 – present
      Founder and Principal Consultant
      Independent CI practice, now delivering congress booth intelligence as ConferenceIQ
    • 2009 – 2010
      Account Director, CIS / Prescient Healthcare Group
      Led CI projects and research teams across multiple indications
    • 2006 – 2009
      Director of Research, Deallus
      Key account management, war-gaming and analyst training in congress elicitation
    Project leadership Pharma commercial experts

    Our project managers and senior consultants bring 15+ years of pharma commercial experience across the full drug life cycle, from pipeline and launch to lifecycle management and loss of exclusivity, with deep disease-area knowledge.

    Associate network PhD-qualified associates

    For larger meetings we add experienced associates with clinical pharmacy, medical information and market access backgrounds, so parallel sessions, interviews and the exhibit hall are covered at once.

    Coverage model Scaled to the congress

    From a single consultant on a focused question to a coordinated team across a five-day meeting, with one senior lead accountable for delivery.

    Ethics and compliance

    Intelligence you can use with confidence

    Our research is conducted ethically and transparently, in line with the SCIP Code of Ethics and the expectations of pharma compliance teams.

    • Interviewers always identify themselves honestly and never misrepresent who they are
    • Conversations with competitor booth teams are open and honest: we gather only what companies choose to share publicly at the congress
    • No solicitation of confidential or proprietary information
    • Adverse events identified during research are reported under your pharmacovigilance procedures
    • Source confidentiality protected in every report
    • Confidentiality agreements in place with every client and associate
    Perspectives

    How we think about congress intelligence

    Short views from our work on the congress floor.

    Exhibit hall

    The booth is a strategy document hiding in plain sight

    Competitors rehearse launch messages on their stands months before they appear in market. Tracked across successive congresses, booth changes are one of the earliest signals of a positioning shift.

    KOL research

    Reaction is most honest in the hour after the data

    Investigators speak most candidly while a presentation is fresh. Interviews timed around the session, rather than weeks later, capture opinion before it settles into a consensus line.

    Planning

    Coverage should start from the decision, not the agenda

    A congress programme has hundreds of sessions. Mapping each interview and session to a specific KIQ is what turns attendance into intelligence a brand team can use.

    Contact

    Brief us on your next congress.

    Tell us the meeting, your competitors and the decisions the intelligence will inform. We will respond with a coverage plan and proposal.

    Briefs, proposals and access codesbriefings@conferenceiq.co.ukCongress briefs, sample briefings and replacement codes
    OfficeLondon, United KingdomOn site across the US and Europe